Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Leukocyte Biology|August 9, 2008
Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) toleranceRajesh K Aneja, Allan Tsung, Hanna Sjodin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 12, 2002
Liposomal NAD(+) prevents diminished O(2) consumption by immunostimulated Caco-2 cellsAbrar U Khan, Russell L Delude, Yong Y Han, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 31, 2005
The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cellsMeaghan E Killeen, Joshua A Englert, Donna Beer Stolz, et al.
Critical Care Medicine|September 22, 2007
Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted antioxidantsMitchell P Fink, Carlos A Macias, Jingbo Xiao, et al.
Shock (Augusta, Ga.)|November 15, 2011
Duration and magnitude of hypotension and monocyte deactivation in patients with community-acquired pneumoniaPeter M Simon, Russell L Delude, MinJae Lee, et al.
American Journal of Physiology. Cell Physiology|November 12, 2005
HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayersShiguang Liu, Donna B Stolz, Penny L Sappington, et al.
Annals of Surgery|January 25, 2007
Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shockCarlos A Macias, Jeffrey W Chiao, Jingbo Xiao, et al.
Biochemical Pharmacology|July 3, 2007
Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted anti-oxidantsMitchell P Fink, Carlos A Macias, Jingbo Xiao, et al.
Chest|April 14, 2009
Midregional proadrenomedullin as a prognostic tool in community-acquired pneumoniaDavid T Huang, Derek C Angus, John A Kellum, et al.
Pageof 5